Friday, 28 Aug 2026
Subscribe
States Top Leading News States Top Leading News
  • Home
  • Categories
    • Videos
    • Local News
    • Editorial
    • Business
    • Education
    • Entertainment
    • Finance
    • General
    • Lifestyle
    • Health
    • Technology
    • Politics
    • World
    • Press Releases
    • Shop
  • Services
    • Press Release Distribution
    • Biz Directory
    • Video Press Release
  • Career
  • About
    • Corrections Policy
    • Staff Directory
    • Published Pages
    • Legal Disclaimer
  • Contact
Font ResizerAa
STL.NewsSTL.News
Search
  • Home
  • Categories
    • Videos
    • Local News
    • Editorial
    • Business
    • Education
    • Entertainment
    • Finance
    • General
    • Lifestyle
    • Health
    • Technology
    • Politics
    • World
    • Press Releases
    • Shop
  • Services
    • Press Release Distribution
    • Biz Directory
    • Video Press Release
  • Career
  • About
    • Corrections Policy
    • Staff Directory
    • Published Pages
    • Legal Disclaimer
  • Contact
Have an existing account? Sign In
Follow US
© States Top Leading News. All Rights Reserved.

Home » Business » Sanjay Kumar – Charged – Selling Counterfeit Cancer Drugs

Business

Sanjay Kumar – Charged – Selling Counterfeit Cancer Drugs

Martin Smith
Last updated: July 28, 2024 8:03 am
Martin Smith - Editor in Chief
Share
Sanjay Kumar - Charged - Selling Counterfeit Cancer Drugs
Sanjay Kumar - Charged - Selling Counterfeit Cancer Drugs
SHARE

Foreign National, Sanjay Kumar, Charged for Selling Counterfeit Cancer Drugs.

(STL.News) A federal grand jury in Houston, Texas, returned an indictment on July 25, 2024, charging an Indian national, Sanjay Kumar, with shipping and selling tens of thousands of dollars worth of counterfeit oncology pharmaceuticals into the United States.

According to court documents, Sanjay Kumar, 43, of Bihar, India, and his co-conspirators allegedly arranged for the sale and shipment of fake, counterfeit versions of oncology pharmaceuticals—including Keytruda—to individuals in the United States.  Genuine Keytruda is a cancer immunotherapy that is approved in the United States for 19 different indications, including to treat certain types of melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, gastric cancer, cervical cancer, and breast cancer.  Merck Sharp & Dohme LLC, formerly known as Merck Sharp & Dohme Corp., has the exclusive right to authorize the manufacture of Keytruda for introduction into interstate commerce.

Sanjay Kumar was arrested on June 26 in Houston after traveling to the United States to conduct further negotiations aimed at expanding his business selling fake Keytruda in the U.S. market.

Sanjay Kumar is charged with one count of conspiracy to traffic in counterfeit drugs and four counts of trafficking in counterfeit drugs.  If convicted, he faces a maximum penalty of 20 years in prison on each count.

Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the Justice Department’s Criminal Division; U.S. Attorney Alamdar Hamdani for the Southern District of Texas; Special Agent in Charge Mark Dawson of Homeland Security Investigations (HSI) Houston; and Special Agent in Charge Charles Grinstead of the Food and Drug Administration’s (FDA) Office of Criminal Investigations, Kansas City Field Office made the announcement.

HSI and the FDA investigated the case.

Trial Attorneys Jeff Pearlman and Bryce Rosenbower of the Criminal Division’s Computer Crime and Intellectual Property Section and Assistant U.S. Attorney Jay Hileman for the Southern District of Texas are prosecuting the case.

An indictment is merely an allegation.  All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

SOURCE: DOJ

TAGGED:Texas
Share This Article
Twitter Email Copy Link Print
By Martin Smith Editor in Chief
Follow:
Martin Smith is the founder and Editor in Chief of STL.News, an independent digital news publication owned and operated by St. Louis Media, LLC. He founded STL.News in 2016 and oversees its editorial direction and digital publishing operations. His coverage includes business, financial markets, securities litigation, government and regulatory developments, legal news, and St. Louis-area businesses and economic activity.
Best Webhost

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
Google NewsFollow
LinkedInFollow

Popular Posts

When America Knows It’s Time for a Career Change

When America Knows It’s Time for a Career Change: Why Millions of Workers Are Rethinking…

By Martin Smith

Iran’s Embassy in Mexico reports that discussions are underway with FIFA to relocate World Cup matches.

Iran Seeks to Host World Cup Matches in New Negotiations with FIFA Iran's embassy in…

By Martin Smith
Business Loans
States Top Leading News States Top Leading News
Facebook Instagram Pinterest Apple Google

About STL.News

STL.News is an independent digital news publication owned and operated by St. Louis Media, LLC. Founded in 2016, our mission is to provide accurate, timely and accessible local, national and international news, with an emphasis on St. Louis, business and financial markets. Visit our Google page.

  • Marty@STLMedia.Agency
  • 417-529-1133
  • 36 Four Seasons Shopping Center # 310 Chesterfield, Missouri 63017 United States

© 2026 St. Louis Media, LLC dba STL.News. All Rights Reserved.

adbanner
AdBlock Detected
Our site is an advertising supported site. Please whitelist to support our site.
Okay, I'll Whitelist
Welcome Back!

Sign in to your account

Lost your password?